Mark Leonard Singleton - Apr 10, 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & CFO
Signature: /s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol: BVS
Transactions as of: Apr 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/12/2023, 09:14 PM
Previous filing: Mar 27, 2023
Next filing: Jun 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BVS	Class A Common Stock						12.6K	Apr 10, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Award	$0	+52K		$0.00	52K	Apr 10, 2023	Class A Common Stock	52K		Direct	F1, F2
transaction	BVS	Stock Option (Right to Buy)	Award	$0	+136K		$0.00	136K	Apr 10, 2023	Class A Common Stock	136K	$1.16	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2	The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.